Individualisierung der antihypertensiven Therapie bei Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2026)

Christoph H. Saely, Gerit-Holger Schernthaner, Johanna Maria Brix, Renate Klauser-Braun, Emanuel Zitt, Heinz Drexel, Guntram Schernthaner

Open source

DOI: 10.1007/s00508-026-02719-7
Published: 2026-04-30
Container: Wiener klinische Wochenschrift
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00508-026-02719-7,
  title = {Individualisierung der antihypertensiven Therapie bei Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2026)},
  author = {Christoph H. Saely and Gerit-Holger Schernthaner and Johanna Maria Brix and Renate Klauser-Braun and Emanuel Zitt and Heinz Drexel and Guntram Schernthaner},
  year = {2026},
  journal = {Wiener klinische Wochenschrift},
  doi = {10.1007/s00508-026-02719-7},
  url = {https://doi.org/10.1007/s00508-026-02719-7}
}

RIS

TY  - JOUR
TI  - Individualisierung der antihypertensiven Therapie bei Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2026)
AU  - Christoph H. Saely
AU  - Gerit-Holger Schernthaner
AU  - Johanna Maria Brix
AU  - Renate Klauser-Braun
AU  - Emanuel Zitt
AU  - Heinz Drexel
AU  - Guntram Schernthaner
PY  - 2026
JO  - Wiener klinische Wochenschrift
DO  - 10.1007/s00508-026-02719-7
UR  - https://doi.org/10.1007/s00508-026-02719-7
ER  -

APA

Saely, C. H., Schernthaner, G., Brix, J. M., Klauser-Braun, R., Zitt, E., Drexel, H., & Schernthaner, G. (2026). Individualisierung der antihypertensiven Therapie bei Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2026). Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-026-02719-7

Source records

crossref · retrieved 2026-09-26T07:51:45.871Z